Evidence-Based Medicine Guidelines
Menopausal hormone therapy and risk of gallbladder disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Menopausal Hormone Therapy and Risk of Gallbladder Disease." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450221/all/Menopausal_hormone_therapy_and_risk_of_gallbladder_disease.
Menopausal hormone therapy and risk of gallbladder disease. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2026. https://evidence.unboundmedicine.com/evidence/view/EBMG/450221/all/Menopausal_hormone_therapy_and_risk_of_gallbladder_disease. Accessed March 16, 2026.
Menopausal hormone therapy and risk of gallbladder disease. (2026). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/450221/all/Menopausal_hormone_therapy_and_risk_of_gallbladder_disease
Menopausal Hormone Therapy and Risk of Gallbladder Disease [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2026. [cited 2026 March 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450221/all/Menopausal_hormone_therapy_and_risk_of_gallbladder_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Menopausal hormone therapy and risk of gallbladder disease
ID - 450221
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450221/all/Menopausal_hormone_therapy_and_risk_of_gallbladder_disease
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
